CXCL9 and triple-negative breast carcinoma: In normal samples, M1 macrophages comprised the largest proportion, while CXCL9 + macrophages predominated in HER2 + , ER + , and triple-negative breast cancer, accounting for 63.92%, 80.34%, and 44.69%, respectively.